The sustained-release behavior and in vitro and in vivo transfection of pEGFP-loaded core-shell-structured chitosan-based composite particles

被引:6
作者
Wang, Yun [1 ]
Lin, Fu-xing [2 ]
Zhao, Yu [1 ]
Wang, Mo-zhen [2 ]
Ge, Xue-wu [2 ]
Gong, Zheng-xing [1 ]
Bao, Dan-dan [1 ]
Gu, Yu-fang [1 ]
机构
[1] Anhui Med Univ, Affiliated Hosp 1, Dept Plast Surg, Hefei 230032, Anhui, Peoples R China
[2] Univ Sci & Technol China, Dept Polymer Sci & Engn, CAS Key Lab Soft Matter Chem, Hefei, Anhui, Peoples R China
来源
INTERNATIONAL JOURNAL OF NANOMEDICINE | 2014年 / 9卷
基金
中国国家自然科学基金;
关键词
gene therapy; gene transfection; hydroxybutyl chitosan; thiolated N-alkylated chitosan; pEGFP; complex coacervation; GENE-THERAPY; DNA NANOPARTICLES; DELIVERY; VECTORS; DISEASE;
D O I
10.2147/IJN.S58104
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Novel submicron core-shell-structured chitosan-based composite particles encapsulated with enhanced green fluorescent protein plasmids (pEGFP) were prepared by complex coacervation method. The core was pEGFP-loaded thiolated N-alkylated chitosan (TACS) and the shell was pH-and temperature-responsive hydroxybutyl chitosan (HBC). pEGFP-loaded TACS-HBC composite particles were spherical, and had a mean diameter of approximately 120 nm, as measured by transmission electron microscopy and particle size analyzer. pEGFP showed sustained release in vitro for >15 days. Furthermore, in vitro transfection in human embryonic kidney 293T and human cervix epithelial cells, and in vivo transfection in mice skeletal muscle of loaded pEGFP, were investigated. Results showed that the expression of loaded pEGFP, both in vitro and in vivo, was slow but could be sustained over a long period. pEGFP expression in mice skeletal muscle was sustained for >60 days. This work indicates that these submicron core-shell-structured chitosan-based composite particles could potentially be used as a gene vector for in vivo controlled gene transfection.
引用
收藏
页码:4965 / 4978
页数:14
相关论文
共 34 条
[1]   Delivering the goods: viral and non-viral gene therapy systems and the inherent limits on cargo DNA and internal sequences [J].
Atkinson, Helen ;
Chalmers, Ronald .
GENETICA, 2010, 138 (05) :485-498
[2]   Viability of Long-Term Gene Therapy in the Cochlea [J].
Atkinson, Patrick J. ;
Wise, Andrew K. ;
Flynn, Brianna O. ;
Nayagam, Bryony A. ;
Richardson, Rachael T. .
SCIENTIFIC REPORTS, 2014, 4
[3]   Chitosan-based hydrogels for controlled, localized drug delivery [J].
Bhattarai, Narayan ;
Gunn, Jonathan ;
Zhang, Miqin .
ADVANCED DRUG DELIVERY REVIEWS, 2010, 62 (01) :83-99
[4]   Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles [J].
Bravo-Osuna, Irene ;
Vauthier, Christine ;
Farabollini, Alessandra ;
Palmieri, Giovanni Filippo ;
Ponchel, Gilles .
BIOMATERIALS, 2007, 28 (13) :2233-2243
[5]   Chitosans for delivery of nucleic acids [J].
Buschmann, Michael D. ;
Merzouki, Abderrazzak ;
Lavertu, Marc ;
Thibault, Marc ;
Jean, Myriam ;
Darras, Vincent .
ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (09) :1234-1270
[6]   Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease [J].
Cavazzana-Calvo, M ;
Hacein-Bey, S ;
Basile, CD ;
Gross, F ;
Yvon, E ;
Nusbaum, P ;
Selz, F ;
Hue, C ;
Certain, S ;
Casanova, JL ;
Bousso, P ;
Le Deist, F ;
Fischer, A .
SCIENCE, 2000, 288 (5466) :669-672
[7]   Temperature-responsive hydroxybutyl chitosan for the culture of mesenchymal stem cells and intervertebral disk cells [J].
Dang, JM ;
Sun, DDN ;
Shin-Ya, Y ;
Sieber, AN ;
Kostuik, JP ;
Leong, KW .
BIOMATERIALS, 2006, 27 (03) :406-418
[8]   Immunological properties of engineered nanomaterials [J].
Dobrovolskaia, Marina A. ;
Mcneil, Scott E. .
NATURE NANOTECHNOLOGY, 2007, 2 (08) :469-478
[9]   Gene therapy of severe combined immunodeficiency disease : proof of principle of efficiency and safety issues. Gene therapy, primary immunodeficiencies, retrovirus, lentivirus, genome [J].
Fischer, A ;
Hacein-Bey-Abina, S ;
Lagresle, C ;
Garrigue, A ;
Cavazana-Calvo, M .
BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2005, 189 (05) :779-785
[10]  
FLOTTE TR, 1995, GENE THER, V2, P357